Texas Permanent School Fund Corp lessened its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 3.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 85,125 shares of the company’s stock after selling 3,131 shares during the period. Texas Permanent School Fund Corp’s holdings in Encompass Health were worth $5,717,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of EHC. Cary Street Partners Investment Advisory LLC acquired a new stake in Encompass Health in the second quarter valued at approximately $36,000. Worth Asset Management LLC purchased a new stake in shares of Encompass Health in the 1st quarter valued at approximately $35,000. Belpointe Asset Management LLC raised its holdings in shares of Encompass Health by 88.2% in the 1st quarter. Belpointe Asset Management LLC now owns 781 shares of the company’s stock valued at $42,000 after purchasing an additional 366 shares in the last quarter. Quarry LP purchased a new stake in shares of Encompass Health during the 1st quarter worth $42,000. Finally, Pinebridge Investments L.P. acquired a new position in shares of Encompass Health during the second quarter worth $57,000. Institutional investors and hedge funds own 92.66% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on EHC shares. Mizuho raised their price target on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday. Truist Financial raised their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Wednesday, February 7th. Royal Bank of Canada restated an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a report on Friday. Finally, Stephens restated an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health currently has an average rating of “Buy” and a consensus price target of $79.89.
Encompass Health Stock Performance
Shares of EHC stock opened at $72.93 on Monday. Encompass Health Co. has a 52-week low of $51.15 and a 52-week high of $76.84. The stock’s 50-day moving average price is $68.70 and its 200 day moving average price is $67.51. The company has a quick ratio of 1.27, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of $7.31 billion, a PE ratio of 21.02, a price-to-earnings-growth ratio of 1.31 and a beta of 0.92.
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
- Five stocks we like better than Encompass Health
- The 3 Best Retail Stocks to Shop for in August
- Uber quadruples EPS estimates, but is growth decelerating?
- What does consumer price index measure?
- 3 stocks set to benefit from record Valentine’s Day spending
- Where Do I Find 52-Week Highs and Lows?
- Tradeweb is a disruptive pure play on financial market liquidity
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.